# Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

> **NCT01015638** · PHASE4 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 36 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Clindamycin and BPO 5% gel
- **DRUG:** Clindamycin phosphate and benzoyl peroxide 2.5% gel.

## Key facts

- **NCT ID:** NCT01015638
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01015638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01015638, "Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01015638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*